Market Trends J&J suing Samsung Bioepis over Stelara biosimilar: report (JNJ:NYSE)By admin8996erT0allFebruary 25, 2025 Sundry Photography/iStock Editorial via Getty ImagesJohnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to…
